Oxford Nanopore Technologies plc
Oxford Nanopore Technologies plc (ONTTF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
onttf · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Oxford Nanopore Technologies plcYou ONTTF | $1.8B | N/A | — | — |
 BioArctic AB (publ) BRCTF | $3.1B | 27.80x | -41.7% | $11.52 |
 CStone Pharmaceuticals CSPHF | $1.1B | N/A | — | -$0.31 |
 Genus plc GENSF | $2.3B | 64.70x | +35.6% | $0.29 |
 Mesoblast Limited MEOBF | $2.0B | N/A | — | -$0.08 |
 Neuren Pharmaceuticals Limited NURPF | $1.2B | 81.52x | +70.8% | $0.24 |
 Pharma Mar, S.A. PHMMF | $1.8B | 16.86x | -64.7% | $4.36 |
Industry Average 4 peers with valid PE | — | 47.72x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Oxford Nanopore Technologies plc (ONTTF) measures how much investors pay for each dollar of the company's trailing earnings. ONTTF's current PE ratio of N/A is calculated by dividing its stock price of $1.86 by its TTM earnings per share of —.
Frequently asked questions
ONTTF pe ratio · 6 questionsONTTF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $1.86 and TTM EPS of —. Data sourced from Financial Modeling Prep via ONTTF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Oxford Nanopore Technologies plc SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09